![Rainer Fischer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rainer Fischer
Directeur/Bestuurslid bij Indiana Biosciences Research Institute
Actieve functies van Rainer Fischer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Indiana Biosciences Research Institute
![]() Indiana Biosciences Research Institute Miscellaneous Commercial ServicesCommercial Services The Indiana Biosciences Research Institute is a biomedical research organization that aims to solve challenging health problems and improve patient outcomes. The Eli Lilly and Company Diabetes Center of Excellence, located at the institute, is dedicated to studying the molecular basis of diabetes and its complications. The non-profit company is based in Indianapolis, IN. The company's research focuses on translating disease hypotheses into potential therapies. Alan Palkowitz has been the CEO of the company since 2020. | Directeur/Bestuurslid | - | - |
Corporate Officer/Principal | 19-04-2019 | - | |
Algemeen Directeur | 01-10-2017 | 19-04-2019 | |
Hoofd Techniek/Wetenschap/O&O | 01-10-2016 | 19-04-2019 |
Loopbaan van Rainer Fischer
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Indiana Biosciences Research Institute
![]() Indiana Biosciences Research Institute Miscellaneous Commercial ServicesCommercial Services The Indiana Biosciences Research Institute is a biomedical research organization that aims to solve challenging health problems and improve patient outcomes. The Eli Lilly and Company Diabetes Center of Excellence, located at the institute, is dedicated to studying the molecular basis of diabetes and its complications. The non-profit company is based in Indianapolis, IN. The company's research focuses on translating disease hypotheses into potential therapies. Alan Palkowitz has been the CEO of the company since 2020. | Commercial Services |
- Beurs
- Insiders
- Rainer Fischer
- Ervaring